The c-Rel transcription factor and B-cell proliferation: A deal with the devil

Oncogene

Volumn 23, Issue 13, 2004, Pages 2275-2286

  Gilmore, Thomas D ^a   Kalaitzidis, Demetrios ^a   Liang, Mei Chih ^a   Starczynowski, Daniel T ^a  

^a Boston University   (United States)

Author keywords

B cell; c Rel; Gene amplification; Lymphoma; NF b; Rel

Indexed keywords

APOPTOSIS INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN C JUN; PROTEIN P50; RECEPTOR SUBUNIT; STAT1 PROTEIN; TRANSCRIPTION FACTOR REL; UNCLASSIFIED DRUG;

APOPTOSIS; B CELL LYMPHOMA; B LYMPHOCYTE; BINDING SITE; CANCER CELL CULTURE; CANCER LOCALIZATION; CARBOXY TERMINAL SEQUENCE; CELL LINEAGE; CELL MATURATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; DNA BINDING; DNA FLANKING REGION; GENE AMPLIFICATION; GENE EXPRESSION; GENE INSERTION; GENE OVEREXPRESSION; GENE REARRANGEMENT; GENETIC CODE; HEMATOPOIETIC CELL; HUMAN; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; LARGE CELL LYMPHOMA; LEUKEMOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; LYMPHOID CELL; MALIGNANT TRANSFORMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTO ONCOGENE; RETROVIRUS; REVIEW; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; B CELL LEUKEMIA; CELL DIVISION; GENETICS; PHYSIOLOGY;

ANIMALIA; AVES; INSERTION SEQUENCES; MAMMALIA; UNIDENTIFIED RETROVIRUS;

ANIMALS; B-LYMPHOCYTES; CELL DIVISION; HUMANS; LEUKEMIA, B-CELL; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-REL; SIGNAL TRANSDUCTION;

EID: 1842432464     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207410     Document Type: Review

References (151)

1. Agresti A and Vercelli D. (2002). Mol. Immunol., 38, 849-859.
2. Alizadeh AA, Eisen M, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani G, Sherlock G, Chan WC, Greiner TC, Weisenburger DE, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO and Staudt LM. (2000). Nature, 403, 503-511.
3. Andjelic S, Hsia C, Suzuki H, Kadowaki T, Koyasu S and Liou H-C. (2000). J. Immunol., 165, 3860-3867.
4. Avet-Loiseau H, Vigier M, Moreau A, Mellerin MP, Gaillard F, Harousseau JL, Bataille R and Milpied N. (1997). Br. J. Haematol., 91, 119-122.
5. Baldwin AS. (2001). J. Clin. Invest., 107, 241-246.
6. Barkett M and Gilmore TD. (1999). Oncogene, 18, 6910-6924.
7. Barth TF, Bentz M, Leithauser F, Stilgenbauer S, Siebert R, Schlotter M, Schlenk RF, Döhner H and Möller P. (2001). Genes Chromosomes Cancer, 31, 316-325.
8. Barth TFE, Döhner H, Werner CA, Stilgenbauer S, Schlotter M, Pawlita M, Lichter P, Möller P and Bentz M. (1998). Blood, 91, 4321-4330.
9. Barth TFE, Martin-Subero JI, Joos S, Menz CK, Hasel C, Mechtersheimer G, Parwaresch RM, Lichter P, Siebert R and Möller P. (2003). Blood, 101, 3681-3686.
10. Bentz M, Werner CA, Döhner H, Joos S, Barth TF, Siebert R, Schroder M, Stilgenbauer S, Fischer K, Möller P and Lichter P. (1996). Blood, 88, 1437-1444.
11. Bureau F, Vanderplasschen A, Jaspar F, Minner F, Pastoret PP, Merville MP, Bours V and Lekeux P. (2002). Blood, 99, 3683-3691.
12. Cabannes E, Khan G, Aillet F, Jarrett RF and Hay RT. (1999). Oncogene, 18, 3063-3070.
13. Cabatingan MS, Schmidt MR, Sen R and Woodland RT. (2002). J. Immunol., 169, 6795-6805.
14. Cariappa A, Liou H-C, Horwitz BH and Pilai S. (2000). J. Exp. Med., 192, 1175-1182.
15. Carrasco D, Cheng J, Lewin A, Warr G, Yang H, Rizzo C, Rosas F, Snapper C and Bravo R. (1998). J. Exp. Med., 187, 973-984.
16. Carrasco D, Rizzo CA, Dorfman K and Bravo R. (1996). EMBO J., 15, 3640-3650.
17. Carrasco D, Weih F and Bravo R. (1994). Development, 120, 2991-3004.
18. Chang NS. (2002). J. Biol. Chem., 277, 10323-10331.
19. Chen C, Edelstein LC and Gélinas C. (2000). Mol. Cell. Biol., 20, 2687-2695.
20. Chen E and Li CC. (1998). Biochem. Biophys. Res. Commun., 249, 728-734.
21. Chen E, Hrdlicková R, Nehyba J, Longo DL, Bose Jr HR and Li C-CH. (1998). J. Biol. Chem., 273, 35201-35207.
22. Cheng S, Hsia CY, Leone G and Liou H-C. (2003). Oncogene, 22, 8472-8486.
23. Davis RE, Brown KD, Siebenlist U and Staudt LM. (2001). J. Exp. Med., 194, 1861-1874.
24. Doerre S and Corley RB. (1999). J. Immunol., 163, 269-277.
25. Donnelly GB, Teruya-Feldstein J, Quin J, Zelenetz AD, Houldsworth J and Chaganti RS. (2001). Blood, 98, 302.
26. Dyer MJ. (2003). Int. J. Hematol., 77, 315-320.
27. Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H and Dörken B. (1999). Blood, 94, 3129-3134.
28. Emmerich F, Theurich S, Hummel M, Haeffker A, Vry MS, Döhner K, Bommert K, Stein H and Dörken B. (2003). J. Pathol., 201, 413-420.
29. Fan Y, Rayet B and Gélinas C. (2003). Oncogene, (in press).
30. Fields ER, Seufzer BJ, Oltz EM and Miyamoto S. (2000). J. Immunol., 164, 297-305.
31. Forsyth NR, Wright WE and Shay JW. (2002). Differentiation, 69, 188-197.
32. Gerondakis S, Strasser A, Metcalf G, Grigoriadis G, Scheerlinck JY and Grumont RJ. (1996). Proc. Natl. Acad. Sci. USA, 93, 3405-3409.
33. Ghosh S and Karin M. (2002). Cell, 109, S81-S96.
34. Gilmore TD, Cormier C, Jean-Jacques J and Gapuzan M-E. (2001). Oncogene, 20, 7098-7103.
35. Gilmore TD, Gapuzan M-E, Kalaitzidis D and Starczynowski D. (2002). Cancer Lett., 181, 1-9.
36. Gilmore TD, Jean-Jacques J, Richards R, Cormier C, Kim J and Kalaitzidis D. (2003). Virology, 316, 9-16.
37. Gilmore TD, White DW, Sarkar S and Sif S. (1995). The DNA Provirus: Howard Temin's Scientific Legacy. Cooper GM, Greenberg Temin R, Sugden B (eds). American Society for Microbiology Press: Washington, DC, pp. 109-128.
38. Gilmore TD. (1999). Oncogene, 18, 6925-6937.
39. Gilmore TD. (2003). Rel/NF-κ B transcription factors at www.nf-kb.org.
40. Glineur C, Davioud-Charvet E and Vandenbunder B. (2000). Biochem. J., 352, 583-591.
41. Goff LK, Neat MJ, Crawley CR, Jones L, Jones E, Lister TA and Gupta RK. (2000). Br. J. Haematol., 111, 618-625.
42. Grossmann M, Metcalf D, Merryfull J, Beg A, Baltimore D and Gerondakis S. (1999). Proc. Natl. Acad. Sci. USA, 96, 11848-11853.
43. Grossmann M, O'Reilly LA, Gugasyan R, Strasser A, Adams JM and Gerondakis S. (2000). EMBO J., 19, 6351-6360.
44. Grumont RJ and Gerondakis S. (1994). Cell Growth Differ., 5, 1321-1331.
45. Grumont RJ and Gerondakis S. (2000). J. Exp. Med, 191, 1281-1292.
46. Grumont RJ, Richardson IB, Gaff C and Gerondakis S. (1993). Cell Growth Differ., 4, 731-743.
47. Grumont RJ, Rourke IJ and Gerondakis S. (1999). Genes Dev., 12, 400-411.
48. Grumont RJ, Strasser A and Gerondakis S. (2002). Mol. Cell, 10, 1283-1294.
49. Harling-McNabb L, Deliyannis G, Jackson DC, Gerondakis S, Grigoriadis G and Brown LE. (1999). Int. Immunol., 11, 1431-1439.
50. Harnett M. (1996). Immunol. Today, 17, 4.
51. Hayashi K, Nittono R, Okamoto N, Tsuji S, Hara Y, Goitsuka R and Kitamura D. (2000). Proc. Natl. Acad. Sci. USA, 97, 2755-2760.
52. Heckman CA, Mehew JW and Boxer LM. (2002). Oncogene, 21, 3898-3908.
53. Houldsworth J, Mathew S, Rao PH, Dyomina K, Louie DC, Parsa N, Offit K and Chaganti RS. (1996). Blood, 87, 25-29.
54. Houldsworth J, Olshen AB, Cattoretti G, Donnelly GB, Teruya-Feldstein J, Qin J, Palanisamy N, Shen Y, Dyomina K, Petlakh M, Pan Q, Zelenetz AD, Dalla-Favera R and Chaganti RS. (2003). Blood, (in press).
55. Hrdlicková R, Nehyba J and Bose Jr HR. (1995a). J. Virol., 69, 3369-3380.
56. Hrdlicková R, Nehyba J and Humphries EH. (1994). J. Virol., 68, 2371-2382.
57. Hrdlicková R, Nehyba J, Roy A, Humphries EH and Bose Jr HR. (1995b). J. Virol., 69, 403-413.
58. Hsia CY, Cheng S, Owyang AM, Dowdy SF and Liou H-C. (2002). Int. Immunol., 14, 905-916.
59. Hu CJ, Rao S, Ramirez-Bergeron DL, Garrett-Sinha LA, Gerondakis S, Clark MR and Simon MC. (2001). Immunity, 15, 545-555.
60. Huang D, Chen Y, Ruetsche M, Phelps CB and Ghosh G. (2001). Structure, 9, 669-678.
61. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RS and Dalla-Favera R. (1997). Nat. Genet., 17, 226-230.
62. Ishikawa H, Asano M, Kanda T, Gélinas C and Ito Y. (1993). Oncogene, 8, 2889-2896.
63. Jin J and Harper JW. (2003). Cancer Cell, 3, 517-518.
64. Joos S, Granzow M, Holtgreve-Grez H, Siebert R, Harder L, Martin-Subero JI, Wolf J, Adamowicz M, Barth TF, Lichter P and Jauch A. (2003). Int. J. Cancer, 103, 489-495.
65. Joos S, Menz CK, Wrobel G, Siebert R, Gesk S, Ohl S, Mechtersheimer G, Trumper L, Möller P, Lichter P and Barth TF. (2002). Blood, 99, 1381-1387.
66. Joos S, Otaño-Joos MI, Ziegler S, Brüderlein S, du Manoir S, Bentz M, Möller P and Lichter P. (1996). Blood, 87, 1571-1578.
67. Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M and Nielsen PJ. (1999). Immunity, 11, 547-554.
68. Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, Miosge LA, Cook MC, Kucharska EM, Hara H, Penninger JM, Domashenz H, Hong NA, Glynne RJ, Nelms KA and Goodnow CC. (2003). Immunity, 18, 751-762.
69. Jungnickel B, Staratschek-Jox A, Bräuninger A, Spieker T, Wolf J, Diehl V, Hansmann M-L, Rajewsky K and Küppers R. (2002). J. Exp. Med., 191, 395-401.
70. Kabrun N, Bumstead N, Hayman MJ and Enrietto PJ. (1990). Mol. Cell. Biol., 10, 4788-4794.
71. Kaku H, Horikawa K, Obata Y, Kato I, Okamoto H, Sakaguchi N, Gerondakis S and Takatsu K. (2002). Int. Immunol., 14, 1055-1064.
72. Kalaitzidis D and Gilmore TD. (2002). Genes Chromosomes Cancer, 34, 129-135.
73. Kalaitzidis D, Davis RE, Rosenwald A, Staudt LM and Gilmore TD. (2002). Oncogene, 21, 8759-8768.
74. Kamens J, Richardson P, Mosialos G, Brent R and Gilmore T. (1991). Mol. Cell. Biol., 10, 2840-2847.
75. Karin M, Cao Y, Greten FR and Li ZW. (2002). Nat. Rev. Cancer, 2, 301-310.
76. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ, Maliszewski CR, Witte ON and Perlmutter RM. (1995). Immunity, 3, 301-312.
77. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, Davidson L, Muller S, Kantor AB, Herzenberg LA, Rosen FS and Sideras P. (1995). Immunity, 3, 283-299.
78. Kim H, You S, Farris J, Kong BW, Christman SA, Foster LK and Foster DN. (2002). Exp. Cell Res., 272, 199-208.
79. Kim SH, Mitchell M, Fujii H, Llanos S and Peters G. (2003). Proc. Natl. Acad. Sci. USA, 100, 211-216.
80. Kistler B, Rolink R, Marienfeld R, Neumann M and Wirth T. (1998). J. Immunol., 160, 2308-2317.
81. Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D and Gerondakis S. (1995). Genes Dev., 9, 1965-1977.
82. Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B and Scheidereit C. (1999). Oncogene, 18, 943-953.
83. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ and Sonenshein GE. (1995). J. Exp. Med., 181, 1169-1177.
84. Li J, Joo SH and Tsai MD. (2003). Biochemistry, 42, 13476-13483.
85. Liang M-C, Bardhan S, Li C, Pace EA, Porco Jr JA and Gilmore TD. (2003). Mol. Pharmacol., 64, 123-131.
86. Liou H-C and Hsia CY. (2003). BioEssays, 25, 767-780.
87. Liou H-C, Jin Z, Tumang J, Andjelic S, Smith KA and Liou ML. (1999). Int. Immunol., 11, 361-371.
88. Liou H-C, Sha WC, Scott ML and Baltimore D. (1994). Mol. Cell. Biol., 14, 5349-5359.
89. Liu J and Beller DJ. (2002). J. Immunol., 169, 581-586.
90. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA and Copeland NG. (2003). Nat. Immunol., 4, 525-532.
91. Lu D, Thompson JD, Gorski GK, Rice NR, Mayer MG and Yunis JJ. (1991). Oncogene, 6, 1235-1241.
92. Lund AH, Turner G, Trubetskoy A, Verhoeven E, Wientjens E, Hulsman D, Russell R, DePinho RA, Lenz J and van Lohuizen M. (2002). Nat. Genet., 32, 160-165.
93. Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD and Whittaker S. (2003). Genes Chromosomes Cancer, 37, 176-185.
94. Martin AG and Fresno M. (2000). J. Biol. Chem., 275, 24383-24391.
95. Martin AG, San-Antonio B and Fresno M. (2001). J. Biol. Chem., 276, 15840-15849.
96. Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG, Garcia-Conde J, Dyer MJ, Levy R, Pinkel D and Lossos IS. (2003). Blood, 101, 3109-3117.
97. Martin-Subero JI, Gesk S, Harder L, Sonoki T, Tucker PW, Schlegelberger B, Grote W, Novo FJ, Calasanz MJ, Hansmann ML, Dyer MJ and Siebert R. (2002). Blood, 99, 1474-1477.
98. Martin-Subero JI, Knippschild U, Harder L, Barth TF, Riemke J, Grohmann S, Gesk S, Hoppner J, Möller P, Parwaresch RM and Siebert R. (2003). Leukemia, 17, 2214-2219.
99. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS and Mak TW. (1997). Science, 275, 540-543.
100. Miyamoto S, Chiao P and Verma IM. (1994a). Mol. Cell. Biol., 14, 3276-3282.
101. Miyamoto S, Chiao P and Verma IM. (1994b). Proc. Natl. Acad. Sci. USA, 91, 5056-5060.
102. Miyamoto S, Seufzer BJ and Shumway SD. (1998). Mol. Cell. Biol., 18, 19-29.
103. Moscat J, Diaz-Meco MT and Rennert P. (2003). EMBO Rep., 4, 31-36.
104. Mosialos G, Hamer P, Capobianco AJ, Laursen R and Gilmore TD. (1991). Mol. Cell. Biol., 11, 5867-5877.
105. Nakamura T, Yamazaki Y, Saiki Y, Moriyama M, Largaespada DA, Jenkins NA and Copeland NG. (2000). Mol. Cell. Biol., 20, 3178-3186.
106. Neat MJ, Foot N, Jenner M, Goff L, Ashcroft K, Burford D, Dunham A, Norton A, Lister TA and Fitzgibbon J. (2001). Genes Chromosomes Cancer, 32, 236-243.
107. Neiman PE, Grbic JJ, Polony TS, Kimmel R, Bowers SJ, Delrow J and Beemon KL. (2003). Oncogene, 22, 1073-1086.
108. Neumann M, Tsapos K, Scheppler JA, Ross J and Franza Jr BR. (1992). Oncogene, 7, 2095-2104.
109. Newton K and Dixit V. (2003). Curr. Biol., 13, 1247-1251.
110. Okkenhaug K and Vanhaesebroeck B. (2003). Nat. Rev. Immunol., 3, 317-330.
111. Palanisamy N, Abou-Elella AA, Chaganti SR, Houldsworth J, Offit K, Louie DC, Terayu-Feldstein J, Cigudosa JC, Rao PH, Sanger WG, Weisenburger DD and Chaganti RS. (2002). Genes Chromosomes Cancer, 33, 114-122.
112. Pappu R, Chenng AM, Li B, Gong Q, Chiu C, Griffin N, White M, Sleckman BP and Chan AC. (1999). Science, 286, 1949-1954.
113. Petro JB and Khan WN. (2001). J. Biol Chem., 276, 1715-1719.
114. Petro JB, Rahman SM, Ballard DW and Khan WN. (2000). J. Exp. Med., 191, 1745-1753.
115. Pohl T, Gugasyan R, Grumont TJ, Strasser A, Metcalf D, Tarlinton D, Sha W, Baltimore D and Gerondakis S. (2002). Proc. Natl. Acad. Sci. USA, 99, 4514-4519.
116. Popescu NC and Zimonjic DB. (2002). J. Cell Mol. Med., 6, 151-159.
117. Rao PH, Houldsworth J, Dyomina K, Parsa NZ, Cigudosa JC, Louie DC, Popplewell L, Offit K, Jhanwar SC and Chaganti RS. (1998). Blood, 92, 234-240.
118. Rayet B, Fan Y and Gélinas C. (2003). Mol. Cell. Biol., 23, 1520-1533.
119. Romieu-Mourez R, Kim DW, Shin SM, Demicco EG, Landesman-Bollag E, Seldin DC, Cardiff RD and Sonenshein GE. (2003). Mol. Cell. Biol., 23, 5738-5754.
120. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T and Staudt LM. (2002). N. Engl. J. Med., 346, 1937-1947.
121. Sachdev S and Hannink M. (1998). Mol. Cell. Biol., 18, 5445-5456.
122. Sachdev S, Diehl JA, McLinsey TA, Hans A and Hannink M. (1997). Oncogene, 14, 2585-2594.
123. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW and Dyer MJ. (2001). Blood, 98, 3413-3420.
124. Savage KJ, Monti S, Kutok JL, Cattoretti G, Neuberg D, De Leval L, Kurtin P, Dal Cin P, Ladd C, Feuerhake F, Aguiar RC, Li S, Salles G, Berger F, Jing W, Pinkus GS, Habermann T, Dalla-Favera R, Harris NL, Aster JC, Golub TR and Shipp MA. (2003). Blood, 102, 3871-3879.
125. Schmidt CS, Liu J, Zhang T, Song HY, Sandusky G, Mintze K, Benschop RJ, Glasebrook A, Yang DD and Na S. (2003). J. Exp. Med., 197, 51-62.
126. Schwartz RC and Witte ON. (1988). Virology, 165, 182-190.
127. Shaffer AL, Rosenwald A and Staudt LM. (2002). Nat. Rev. Immunol., 2, 920-933.
128. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR. (2002). Nat. Med., 8, 68-74.
129. Shumway DS, Maki M and Miyamoto S. (1999). J. Biol. Chem., 274, 30874-30881.
130. Starczynowski DT, Reynolds JG and Gilmore TD. (2003). Oncogene, 22, 6928-6936.
131. Suzuki H, Matsuda S, Terauchi Y, Fujiwara M, Ohteki T, Asano T, Behrens TW, Kouro T, Takatsu K, Kadowaki T and Koyasu S. (2003). Nat. Immunol., 4, 280-286.
132. Suzuki T, Shen H, Akagi K, Morse HC, Malley JD, Naiman DQ, Jenkins NA and Copeland NG. (2002). Nat. Genet., 32, 166-174.
133. Tam WF, Wang W and Sen R. (2001). Mol. Cell. Biol., 21, 4837-4846.
134. Tamura A, Miura I, Iida S, Yokota S, Horiike S, Nishida K, Fujii H, Nakamura S, Seto M, Ueda R and Taniwaki M. (2001). Cancer Genet. Cytogenet., 129, 1-9.
135. Tan JE, Wong SC, Gan SK, Xu S and Lam KP. (2001). J. Biol. Chem., 276, 20055-20063.
136. Tarte K, Zhan F, De Vos J, Klein B and Shaughnessy J. (2003). Blood, 102, 592-600.
137. Tolnay M, Vereshchagina LA and Tsokos GC. (2002). J. Immunol., 169, 6236-6243.
138. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I, Miura K, Harada S, Kikuchi M, Komatsu H, Banno S, Wakita A, Nakamura S, Eimoto T and Ueda R. (2000). Leukemia, 14, 449-456.
139. Tumang JR, Hsia CY, Tian W, Bromberg JF and Liou H-C. (2002). Cell Immunol., 217, 47-57.
140. Tumang JR, Owyang A, Andjelic S, Jin Z, Hardy RR, Liou ML and Liou H-C. (1998). Eur. J. Immunol., 28, 4299-4312.
141. Wang D, Feng J, Wen R, Marine JC, Sangster MY, Parganas E, Hoffmeyer A, Jackson CW, Cleveland JL, Murray PJ and Ihle JN. (2000). Immunity, 13, 25-35.
142. Weih F, Carrasco D and Bravo R. (1994). Oncogene, 9, 3289-3297.
143. Werner CA, Dohner H, Joos S, Trumper LH, Baudis M, Barth TF, Ott G, Moller P, Lichter P and Bentz M. (1997). Am. J. Pathol., 151, 335-342.
144. Wessendorf S, Schwaenen C, Kohlhammer H, Kienle D, Wrobel G, Barth TF, Nessling M, Möller P, Döhner H, Lichter P and Bentz M. (2003). Oncogene, 22, 1425-1429.
145. White DW and Gilmore TD. (1996). Oncogene, 13, 891-899.
146. Wood KM, Roff M and Hay RT. (1997). Oncogene, 16, 2131-2139.
147. Xue L, Morris SW, Orihuela C, Tuomanen E, Cui X, Wen R and Wang D. (2003). Nat. Immunol., 4, 857-865.
148. Yamazaki T and Kurosaki T. (2003). Nat. Immunol., 4, 857-865.
149. Zhan F, Tian E, Bumm K, Smith R, Barlogie B and Shaughnessy Jr J. (2003). Blood, 101, 1128-1140.
150. Zhou M, Gu L, Zhu N, Woods WG and Findley HW. (2003). Oncogene, 22, 8137-8144.
151. Zong WX, Edelstein LC, Chen C, Bash J and Gélinas C. (1999). Genes Dev., 13, 382-387.